Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Lai

Showing results (41-50 of 209) with videos related to

Pageof 21
Sort By:
Pediatric Emergency Care|February 26, 2026
Evaluating Guideline-Adherent Antibiotic Use for Skin Infections Using Natural Language Processing: A Pilot StudyJames R Rudloff, Stephanie A Fritz, Albert Lai, et al.
Neuro-Oncology|August 23, 2011
Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumabBenjamin M Ellingson, Timothy F Cloughesy, Albert Lai, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 11, 2012
Impact of 3,4-dihydroxy-6-18F-fluoro-L-phenylalanine PET/CT on managing patients with brain tumors: the referring physician's perspectiveFranziska Walter, Timothy Cloughesy, Martin A Walter, et al.
The American Journal of Managed Care|July 22, 2016
Testing of a tethered personal health record framework for early end-of-life discussionsSeuli Bose-Brill, Matthew Kretovics, Taylor Ballenger, et al.
Neuro-Oncology|December 6, 2013
Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patientsKen Herrmann, Johannes Czernin, Timothy Cloughesy, et al.
Journal of Neuro-Oncology|March 17, 2015
MRI perfusion measurements calculated using advanced deconvolution techniques predict survival in recurrent glioblastoma treated with bevacizumabRobert J Harris, Timothy F Cloughesy, Anthony J Hardy, et al.
Journal of Neuro-Oncology|December 10, 2013
Nonlinear distortion correction of diffusion MR images improves quantitative DTI measurements in glioblastomaDavis C Woodworth, Whitney B Pope, Linda M Liau, et al.
Applied Clinical Informatics|June 9, 2026
Characterizing Parental Use of a HIPAA-Compliant Large Language Model Chatbot in Rare Pediatric Diseases: Insights from Think-Aloud SessionsAnna M Kerr, Christine Bereitschaft, Stephanie Milam, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 28, 2012
Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomasBenjamin M Ellingson, Taryar Zaw, Timothy F Cloughesy, et al.
Journal of Neuro-Oncology|June 28, 2011
Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumabBenjamin M Ellingson, Timothy F Cloughesy, Albert Lai, et al.
Pageof 21

Showing results (41-50 of 209) with videos related to

Sort By:
Pageof 21
Pediatric Emergency Care|February 26, 2026
Evaluating Guideline-Adherent Antibiotic Use for Skin Infections Using Natural Language Processing: A Pilot StudyJames R Rudloff, Stephanie A Fritz, Albert Lai, et al.
Neuro-Oncology|August 23, 2011
Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumabBenjamin M Ellingson, Timothy F Cloughesy, Albert Lai, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 11, 2012
Impact of 3,4-dihydroxy-6-18F-fluoro-L-phenylalanine PET/CT on managing patients with brain tumors: the referring physician's perspectiveFranziska Walter, Timothy Cloughesy, Martin A Walter, et al.
The American Journal of Managed Care|July 22, 2016
Testing of a tethered personal health record framework for early end-of-life discussionsSeuli Bose-Brill, Matthew Kretovics, Taylor Ballenger, et al.
Neuro-Oncology|December 6, 2013
Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patientsKen Herrmann, Johannes Czernin, Timothy Cloughesy, et al.
Journal of Neuro-Oncology|March 17, 2015
MRI perfusion measurements calculated using advanced deconvolution techniques predict survival in recurrent glioblastoma treated with bevacizumabRobert J Harris, Timothy F Cloughesy, Anthony J Hardy, et al.
Journal of Neuro-Oncology|December 10, 2013
Nonlinear distortion correction of diffusion MR images improves quantitative DTI measurements in glioblastomaDavis C Woodworth, Whitney B Pope, Linda M Liau, et al.
Applied Clinical Informatics|June 9, 2026
Characterizing Parental Use of a HIPAA-Compliant Large Language Model Chatbot in Rare Pediatric Diseases: Insights from Think-Aloud SessionsAnna M Kerr, Christine Bereitschaft, Stephanie Milam, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 28, 2012
Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomasBenjamin M Ellingson, Taryar Zaw, Timothy F Cloughesy, et al.
Journal of Neuro-Oncology|June 28, 2011
Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumabBenjamin M Ellingson, Timothy F Cloughesy, Albert Lai, et al.
Pageof 21